Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Neoplasms 3Glioblastoma 3Neuroblastoma 2Lymphoma 2Carcinoma, Non-Small-Cell Lung 2Advanced Malignant Solid Tumor 2Thymoma 1Retinoblastoma 1Resectable Pancreatic Cancer 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Objective Response Rate 1Neoplasm Metastasis 1Myasthenia Gravis 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Hepatoblastoma 1Glioma 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Breast Neoplasms 1Advanced Refractory Solid Tumors 1

Interventions

Granulocyte-Macrophage Colony-Stimulating Factor 2Colony-Stimulating Factors 2fludarabine 1camrelizumab 1Radiofrequency Ablation 1Interleukin-2 1Immune Checkpoint Inhibitors 1Cyclophosphamide 1Adjuvants, Immunologic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Advanced Malignant Solid Tumor × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT03662815 2021-11-16

Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Malignant Tumor

Sir Run Run Shaw Hospital

Phase 1 Unknown
30 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumor

NCT04864379 2021-04-28

Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors

Sir Run Run Shaw Hospital

Phase 1 Unknown
30 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡